A set of molecular biomarkers might better predict the recurrence of bladder cancer than conventional prognostic features such as the stage or grade of the malignancy at the time it is discovered, UT Southwestern Medical Center researchers have found.Once a patient undergoes surgery for the removal of their bladder and lymph nodes -- the standard treatment for muscle-invasive bladder cancer -- researchers say a routine tissue analysis could easily test for the presence of mutated proteins, or biomarkers, that they found to help ascertain the chances that the cancer will return.
A child is more likely to develop bladder cancer later in life if he/she is exposed to second-hand smoke or smokes, say European researchers. A child who starts smoking before the age of 15 is three times as likely to suffer from bladder cancer later in life than a child who doesn't smoke.
by Kristina Collins, The Cancer Blog